In type 2 diabetes, 'something brain-friendly' about GLP-1 receptor agonists - Healio

6/26/2022 12:00:00 AM2 years 10 months ago

PHILADELPHIA — Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker. “In addi…

Source/Disclosures Source: Gerstein HC. Session 8: Stroke and Dementia in Diabetes. Presented at: Heart in Diabetes; June 24-26, 2022; Philadelphia (hybrid meeting). Disclosures: Gerstein repor… [+4230 chars]

full article...

In type 2 diabetes, 'something brain-friendly' about GLP-1 receptor agonists - Healio

PHILADELPHIA &mdash; Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker. &ldquo;In addi…

PHILADELPHIA — Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker. “In addi…